We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
New Addition to Consortium Advancing Occupational Health Science
Product News

New Addition to Consortium Advancing Occupational Health Science

New Addition to Consortium Advancing Occupational Health Science
Product News

New Addition to Consortium Advancing Occupational Health Science


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "New Addition to Consortium Advancing Occupational Health Science"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Owlstone Medical, developer of Breath Biopsy® for applications in early disease detection and precision medicine, has announced it has joined the EU-funded Exposome Project for Health and Occupational Research (EPHOR).

The consortium aims to further elucidate the complex relationships between environment and disease by developing the concept of the “working-life exposome”, which takes into account all occupational and related non-occupational exposures (e.g. lifestyle) throughout the lifespan of an individual. Owlstone Medical will receive funding from the project to provide Breath Biopsy Collection Stations and Kits for the collection of breath samples and will perform analysis on samples received.

EPHOR brings together a consortium of exposure, health and data scientists, and technology partners in order to develop knowledge, methods and tools to characterize the working-life exposome at a far deeper level than has previously been attempted. The consortium will combine large-scale pooling of existing data (>40 cohorts; ~21 million people) and systematically look at a wide range of exposures and diseases. The information generated will be made available via a “working-life toolbox”, allowing scientists to use and enhance the data, methods and models currently in use in exposome research.

Simultaneously, new data will be generated, particularly in the area of respiratory disease, by comparing the exposome and health status of workers in a range of industries with that of the general population. Through this effort, in combination with similar data obtained from blood, non-invasive exposome biomarkers on breath will be developed to enable monitoring of lung health and burden of exposure.

Exposures in the workplace can lead to many forms of disease including cancer, cardiovascular, and respiratory disease, and the total global burden of disease caused by occupational exposures is estimated at 5-7%, similar to the burden resulting from urban air pollution or obesity. Ensuring a healthy work environment is therefore an important goal for government and industry; however, such policies are currently limited to what can be concluded from existing scientific evidence.

Billy Boyle, co-founder and CEO at Owlstone Medical, said: “Environmental exposures, including those from the workplace, are known to have a tremendous impact on the start and progression of disease. The EPHOR project promises to directly address this problem, contributing to reducing the burden of workplace exposure on healthcare systems and helping to improve the general health and wellbeing of the population.” 

Advertisement